Latest Breaking News On - Chiara travagin - Page 1 : comparemela.com

Chiesi Global Rare Diseases Makes Debut in the Endocrinology Landscape with Multiple Presentations at the Endocrine Society s ENDO 2024 Meeting

Chiesi Global Rare Diseases Makes Debut in the Endocrinology Landscape with Multiple Presentations at the Endocrine Society s ENDO 2024 Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of arizonaUnited kingdomChiara travaginMaria fleseriuKevin yuenRebeccaj brownEndocrine societyNational institute of diabetesB corpPituitary center at oregon health science universityChiesi group media contactChiesi groupLifesci communicationsGlobal rare diseases makes debutEndocrinology landscape

Chiesi Global Rare Diseases Announces Publication of Results from Fabry Disease Patient Survey

/PRNewswire/ Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living.

United kingdomUnited statesLisa berryGiacomo chiesiAdam daleyChiara travaginB corpChiesi group media contactsBerry company public relationsChiesi groupGlobal rare diseasesOrphanet journalChiesi global rareHuman geneticsCincinnati childrenHospital medical center

Chiesi Global Rare Diseases Presents Long-Term Data on Treatment with Velmanase Alfa in Alpha-Mannosidosis and Announces Additional Presentations at the 20th Annual WORLDSymposium™ Research Meeting

/PRNewswire/ Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living.

San diegoUnited statesInternational centerCzech republicUnited kingdomNordrhein westfalenRobert hopkinNathalie guffonJohn bernatKhashayar azimpourAnkit mehtaChiara travaginNicole muscholAlessio pappagalloAdam daleyGiacomo chiesi

Chiesi Global Rare Diseases Receives FDA Approval for FILSUVEZ® (birch triterpenes) topical gel for the Treatment of Epidermolysis Bullosa

Chiesi Global Rare Diseases Receives FDA Approval for FILSUVEZ® (birch triterpenes) topical gel for the Treatment of Epidermolysis Bullosa
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomBrett kopelanAlessio pappagalloGiacomo chiesiChiara travaginAmryt pharmaLifesci communicationsB corpAmryt pharmaceuticalsChiesi groupDrug administrationEuropean commissionChiesi group media contactDystrophic epidermolysis bullosaGlobal rare diseases

Chiesi Global Rare Diseases Announces Multiple Presentations at SSIEM Annual Symposium 2023

/PRNewswire/ Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people affected.

United statesÎe de franceUnited kingdomIsrael generalGiacomo chiesiOzlem goker alpanConsiglio nazionale delle ricercheAngela messinaArmand trousseauJohn bernatDavid warnockAdam daleyAlessio pappagalloDominique germainBenedicte heronDerralynn hughes